Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement Firms Have ‘Continuous Monitoring’ Burden To Show Product Safety

This article was originally published in The Tan Sheet

Executive Summary

Former FDA supplement programs head Bill Frankos says the industry bears the burden for monitoring product safety in the marketplace because FDA does not have the same vested interest it has for drugs and medical devices stemming from pre-market approval of the products.

Advertisement

Related Content

Supplement Adverse Event Reports Sprout In Fertile Field Of Social Media
FDA To Fill Frankos' Shoes As Major Dietary Supplement Initiatives Pend
AER Label Guidance Holds To Requiring Full Addresses For OTCs, Supplements
Supplement GMPs Stress Responsibility, Put Firms In Driver’s Seat For Testing

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS107753

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel